“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Create an account and get access to all information about Krystal Biotech, Inc
No Credit card required. Free Credit
No Credit card required. It’s fast, easy, and FREE! 🛠️
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
About
A commercial-stage biotechnology company focused on the discovery, development and commercialization of genetic medicines for high unmet medical needs
| C-Level 6 | VP - Level10 |
| Director37 | Manager41 |
| Others99 | |
| Structure | Email Format |
|---|---|
| <f><last>@ |
|
| <first>@ | John@krystalbio.com |
| <first><last>@ | JohnSmith@krystalbio.com |
| Pain Points | Locations | Technologies |
|---|---|---|
| Build & Release | Pittsburgh, PA | calibration, communication, cgmp, operating procedures, compliance, integrity, operations, gmp |
| CRM Implementation | Coraopolis, PA | communication, e, testing, cgmp, operating procedures, compliance, integrity, troubleshooting, operations, gmp |
| CRM Implementation | Pittsburgh, PA | calibration, communication, cgmp, operating procedures, compliance, integrity, operations, gmp |
| Compliance | Coraopolis, PA | communication, e, testing, cgmp, operating procedures, compliance, integrity, troubleshooting, operations, gmp |
| Compliance | Pittsburgh, PA | calibration, communication, cgmp, operating procedures, compliance, integrity, operations, gmp |
Krystal Biotech, Inc looking to hire in Application Development in Chicago, IL
Krystal Biotech, Inc looking to hire in Application Development in Los Angeles, CA
Krystal Biotech, Inc looking to hire in Application Development in Pittsburgh, PA
Buffer
Cmms
Control case
Dynamics 365
Gcp
Analytics
Ar
Assessment
Audit
Calibration
About Krystal BioAt Krystal Biotech, we bring together the brightest and most eager minds to rele...
View MoreAbout Krystal BioAt Krystal Biotech, we bring together the brightest and most eager minds to rele...
View MoreAbout Krystal Bio:At Krystal Biotech, we bring together the brightest and most eager minds to rel...
View MoreOn October 22, 2025, Krystal Biotech announced the launch of VYJUVEK in Japan for treating dystrophic epidermolysis bullosa. Key Highlights: Original SEC
Read MoreJoseph Pantginis, an analyst from H.C. Wainwright, reiterated the Buy rating on Krystal Biotech. The associated price target remains the same with $240.00.
Read MoreKrystal Biotech (NASDAQ:KRYS) presented its second quarter 2025 financial and operating results on August 4, 2025, highlighting strong revenue growth driven
Read MoreIn a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Krystal Biotech (KRYS – Research Report), with a price target
Read MoreA commercial-stage biotechnology company focused on the discovery, development and commercialization of genetic medicines for high unmet medical needs
Krystal biotech, inc operates in the Biotechnology industry.
Krystal biotech, inc's revenue is $290.51m
Krystal biotech, inc has 201 - 500 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.